Pain after Palliative Radiotherapy for Spine Metastases

Clinical Oncology

Volumn 22, Issue 10, 2010, Pages 828-836

  Zaikova, O ^a   Fossa S D ^a   Kongsgaard, U ^a   Kvaloy S ^a   Giercksky, K E ^a   Skjeldal, S ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Pain; Radiotherapy; Response Criteria; Response Rates; Spine Metastases

Indexed keywords

ANALGESIC AGENT; MORPHINE;

ADULT; AGED; ANALGESIA; ARTICLE; BONE PAIN; BRIEF PAIN INVENTORY; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONSENSUS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; SELF REPORT; SPINE METASTASIS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PALLIATIVE CARE; PROGNOSIS; PROSPECTIVE STUDIES; SPINAL NEOPLASMS; YOUNG ADULT;

EID: 78149496264     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2010.03.008     Document Type: Article

References (35)

1. Loblaw D.A., Laperriere N.J., Mackillop W.J. A population-based study of malignant spinal cord compression in Ontario. Clin Oncol (R Coll Radiol) 2003, 15(4):211-217.
2. Conway R., Graham J., Kidd J., Levack P. What happens to people after malignant cord compression? Survival, function, quality of life, emotional well-being and place of care 1 month after diagnosis. Clin Oncol (R Coll Radiol) 2007, 19(1):56-62.
3. Loblaw D.A., Perry J., Chambers A., Laperriere N.J. Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the Cancer Care Ontario Practice Guidelines Initiative's Neuro-Oncology Disease Site Group. J Clin Oncol 2005, 23(9):2028-2037.
4. Rades D., Stalpers L.J., Veninga T., et al. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol 2005, 23(15):3366-3375.
5. Rades D., Fehlauer F., Schulte R., et al. Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. J Clin Oncol 2006, 24(21):3388-3393.
6. Aass N., Fossa S.D. Pre- and post-treatment daily life function in patients with hormone resistant prostate carcinoma treated with radiotherapy for spinal cord compression. Radiother Oncol 2005, 74(3):259-265.
7. Harris K., Li K., Flynn C., Chow E. Worst, average or current pain in the brief pain inventory: which should be used to calculate the response to palliative radiotherapy in patients with bone metastases?. Clin Oncol (R Coll Radiol) 2007, 19(7):523-527.
8. Kaasa S., Brenne E., Lund J.A., et al. Prospective randomised multicenter trial on single fraction radiotherapy (8 Gyx1) versus multiple fractions (3 Gyx10) in the treatment of painful bone metastases. Radiother Oncol 2006, 79(3):278-284.
9. Hadi S., Fan G., Hird A.E., Kirou-Mauro A., Filipczak L.A., Chow E. Symptom clusters in patients with cancer with metastatic bone pain. J Palliat Med 2008, 11(4):591-600.
10. Hadi S., Zhang L., Hird A., de S.E., Chow E. Validation of symptom clusters in patients with metastatic bone pain. Curr Oncol 2008, 15(5):211-218.
11. van der Linden Y.M., Lok J.J., Steenland E., et al. Single fraction radiotherapy is efficacious: a further analysis of the Dutch bone metastasis study controlling for the influence of retreatment. Int J Radiat Oncol Biol Phys 2004, 59(2):528-537.
12. Roos D.E., Turner S.L., O'Brien P.C., et al. Randomized trial of 8Gy in 1 versus 20Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiother Oncol 2005, 75(1):54-63.
13. Katagiri H., Takahashi M., Inagaki J., et al. Clinical results of nonsurgical treatment for spinal metastases. Int J Radiat Oncol Biol Phys 1998, 42(5):1127-1132.
14. Maranzano E., Bellavita R., Rossi R., et al. Short-course versus split-course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. J Clin Oncol 2005, 23(15):3358-3365.
15. Chow E., Harris K., Fan G., Tsao M., Sze W.M. Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol 2007, 25(11):1423-1436.
16. Chow E., Davis L., Schueller T., et al. A comparison of radiation therapy outcomes of bone metastases employing international consensus endpoints and traditional endpoints. Supp Cancer Ther 2004, 1(3):173-178.
17. George R., Jeba J., Ramkumar G., Chacko A.G., Leng M., Tharyan P. Interventions for the treatment of metastatic extradural spinal cord compression in adults. Cochrane Database Syst Rev 2008, 4. CD006716.
18. Smeland S., Erikstein B., Aas M., Skovlund E., Hess S.L., Fossa S.D. Role of strontium-89 as adjuvant to palliative external beam radiotherapy is questionable: results of a double-blind randomized study. Int J Radiat Oncol Biol Phys 2003, 56(5):1397-1404.
19. Chow E., Wu J.S., Hoskin P., Coia L.R., Bentzen S.M., Blitzer P.H. International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol 2002, 64(3):275-280.
20. Collin C., Wade D.T., Davies S., Horne V. The Barthel ADL Index: a reliability study. Int Disabil Stud 1988, 10(2):61-63.
21. Wade D.T., Collin C. The Barthel ADL Index: a standard measure of physical disability?. Int Disabil Stud 1988, 10(2):64-67.
22. Yates J.W., Chalmer B., McKegney F.P. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 1980, 45(8):2220-2224.
23. Klepstad P., Loge J.H., Borchgrevink P.C., Mendoza T.R., Cleeland C.S., Kaasa S. The Norwegian brief pain inventory questionnaire: translation and validation in cancer pain patients. J Pain Symptom Manage 2002, 24(5):517-525.
24. Cleeland C.S., Gonin R., Hatfield A.K., et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994, 330(9):592-596.
25. Li K.K., Hadi S., Kirou-Mauro A., Chow E. When should we define the response rates in the treatment of bone metastases by palliative radiotherapy?. Clin Oncol (R Coll Radiol) 2008, 20(1):83-89.
26. Shi Q., Wang X.S., Mendoza T.R., Pandya K.J., Cleeland C.S. Assessing persistent cancer pain: a comparison of current pain ratings and pain recalled from the past week. J Pain Symptom Manage 2009, 37(2):168-174.
27. Paul S.M., Zelman D.C., Smith M., Miaskowski C. Categorizing the severity of cancer pain: further exploration of the establishment of cutpoints. Pain 2005, 113(1-2):37-44.
28. Hartsell W.F., Scott C.B., Bruner D.W., et al. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 2005, 97(11):798-804.
29. Collin E., Poulain P., Gauvain-Piquard A., Petit G., Pichard-Leandri E. Is disease progression the major factor in morphine 'tolerance' in cancer pain treatment?. Pain 1993, 55(3):319-326.
30. Finkelstein J.A., Zaveri G., Wai E., Vidmar M., Kreder H., Chow E. A population-based study of surgery for spinal metastases. Survival rates and complications. J Bone Joint Surg Br 2003, 85(7):1045-1050.
31. Jansson K.A., Bauer H.C. Survival, complications and outcome in 282 patients operated for neurological deficit due to thoracic or lumbar spinal metastases. Eur Spine J 2006, 15(2):196-202.
32. Patchell R.A., Tibbs P.A., Regine W.F., et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 2005, 366(9486):643-648.
33. Mendel E., Bourekas E., Gerszten P., Golan J.D. Percutaneous techniques in the treatment of spine tumors: what are the diagnostic and therapeutic indications and outcomes?. Spine 2009, 34(22 Suppl.):S93-S100.
34. Gerszten P.C., Mendel E., Yamada Y. Radiotherapy and radiosurgery for metastatic spine disease: what are the options, indications, and outcomes?. Spine 2009, 34(22 Suppl.):S78-S92.
35. Zaikova O., Giercksky K.E., Fossa S.D., Kvaloy S., Johannesen T.B., Skjeldal S. A Population-based study of spinal metastatic disease in south-east Norway. Clin Oncol (R Coll Radiol) 2009, 21:753-759.